Capital Advisory Group Advisory Services’s Gilead Sciences GILD Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,398	Closed	-$499K	–	313
2022 Q1	$499K	Buy	8,398 +187	+2%	+$12K	0.23%	89
2021 Q4	$596K	Sell	8,211 -3,103	-27%	-$214K	0.26%	91
2021 Q3	$790K	Buy	11,314 +666	+6%	+$46.8K	0.29%	86
2021 Q2	$733K	Buy	10,648 +3,701	+53%	+$247K	0.27%	90
2021 Q1	$449K	Sell	6,947 -48	-0.7%	-$3.1K	0.17%	122
2020 Q4	$408K	Buy	6,995 +4,670	+201%	+$282K	0.17%	108
2020 Q3	$147K	Buy	2,325 +2,284	+5,571%	+$158K	0.08%	161
2020 Q2	$3K	Buy	41 +19	+86%	+$1.46K	﹤0.01%	402
2020 Q1	$1K	Buy	+22	New	+$1.52K	﹤0.01%	406
2019 Q4	–	Sell	-22	Closed	-$1K	–	284
2019 Q3	$1K	Hold	22	–	–	﹤0.01%	412
2019 Q2	$1K	Hold	22	–	–	﹤0.01%	396
2019 Q1	$1K	Hold	22	–	–	﹤0.01%	397
2018 Q4	$1K	Hold	22	–	–	﹤0.01%	372
2018 Q3	$1K	Hold	22	–	–	﹤0.01%	347
2018 Q2	$1K	Hold	22	–	–	﹤0.01%	332
2018 Q1	$1K	Buy	+22	New	+$1.75K	﹤0.01%	322

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Advisory Group Advisory Services's GILD Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 8,398 shares — an estimated $499K sold.

Capital Advisory Group Advisory Services first reported a position in GILD in Q1 2018 and held it in 16 quarters. The position peaked at $790K in Q3 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Capital Advisory Group Advisory Services reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 8,398 Gilead Sciences shares in Q2 2022, an estimated $499K.
Capital Advisory Group Advisory Services first reported a position in Gilead Sciences in Q1 2018 and held it in 16 quarters.
Capital Advisory Group Advisory Services's Gilead Sciences position peaked at $790K in Q3 2021.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.